Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
KLOW may be appropriate for individuals who: Have persistent inflammation impairing recovery Are not responding to conventional therapies Want regenerative support without harsh pharmaceuticals Need multi-tissue healing support Prefer biologically intelligent therapies The Future of Regenerative Peptide Blends KLOW represents the evolution of peptide therapyfrom single-compound experimentation to purpose-driven, synergistic formulations
Pure Wellness, Inside and Out
Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]
Dual-Wavelength in vivo Fiber Photometry Recordings 465nm and 405nm LEDs (Tucker Davis Technologies (TDT), Alachua, FL) were used simultaneously in each rat to excite GCaMP8f and measure intracellular Ca 2+ dynamics
The applicability and superior analytical coverage of this newly developed method were successfully demonstrated by profiling toxin-induced alterations in A549 human lung adenocarcinoma cells exposed to CdCl and cisPt
Avoid repeated temperature cycling
